Does renal function affect the efficacy or safety of a pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis

The efficacy and safety of pharmacoinvasive strategy following fibrinolysis for ST-elevation myocardial infarction (STEMI) in relation to renal function have not been established. Using patient-level data from 4 randomized controlled trials, we examined the efficacy and safety of pharmacoinvasive ve...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2017-11, Vol.193, p.46-54
Hauptverfasser:	Russo, Juan J., Goodman, Shaun G., Cantor, Warren J., Ko, Dennis T., Bagai, Akshay, Tan, Mary K., Di Mario, Carlo, Halvorsen, Sigrun, Le May, Michel, Fernandez-Avilés, Francisco, Scheller, Bruno, Armstrong, Paul W., Borgia, Francesco, Piscione, Federico, Sanchez, Pedro L., Yan, Andrew T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute coronary syndromes Angioplasty Bleeding Cardiovascular disease Clinical outcomes Clinical trials Effectiveness Electrocardiography Epidermal growth factor receptors Fibrinolysis Fibrinolytic Agents - therapeutic use Glomerular filtration rate Glomerular Filtration Rate - drug effects Heart attacks Hemodialysis Humans Impairment Intervention Kidney - drug effects Kidney - physiopathology Kidney diseases Medical imaging Meta-analysis Mortality Myocardial infarction Patients Pharmacology Practice Guidelines as Topic Renal function Safety ST Elevation Myocardial Infarction - drug therapy ST Elevation Myocardial Infarction - physiopathology Strategy Stratigraphy Thrombolysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!